Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martinez, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martinez, F. D.
The Proceedings of the American Thoracic Society 2:157-161 (2005)
© 2005 The American Thoracic Society

Heterogeneity of the Association between Lower Respiratory Illness in Infancy and Subsequent Asthma

Fernando D. Martinez

Arizona Respiratory Center, University of Arizona, Tucson, Arizona

Correspondence and requests for reprints should be addressed to Fernando Martinez, M.D., Swift-McNear Professor of Pediatrics, Director, Arizona Respiratory Center, The University of Arizona, 1501 N. Campbell Avenue, Suite 2349 Tucson, AZ 85724-5030. E-mail: fernando{at}arc.arizona.edu


    ABSTRACT
 TOP
 ABSTRACT
 ASSOCIATION BETWEEN VIRAL...
 HETEROGENEITY OF DETERMINANTS OF...
 CONCLUSIONS
 REFERENCES
 
Viral lower respiratory tract illnesses occurring during the first years of life are associated with increased risk of subsequent asthma, but the mechanisms involved have not been completely elucidated. The available evidence suggests that the factors that explain this connection are heterogeneous. Children who start life with lower levels of airway function appear to be more prone to transient forms of wheezing in the first years of life. "Intrinsic" bronchial hyperresponsiveness, that is, that measured shortly after birth and unrelated to markers of atopy, has been reported to predict both early life wheezing and wheezing occurring during the early school years, independent of atopy. It has also been suggested that both decreased interferon-{gamma} responses measured before any viral lower respiratory illness and increased interferon-{gamma} responses measured at the time of the illness may predispose to such illnesses. Children in whom the former mechanism is involved should be expected to be more atopic later in life, whereas those with the latter mechanism should be less likely to be atopic. This may explain why early viral respiratory illnesses have been found to be both protective against and a risk factor for subsequent atopy in different studies. Current evidence thus suggests that different and often apparently contradictory mechanisms related to airway function, structure, and immune responsiveness may explain the association between viral lower airway illness in early life and subsequent asthma. Future preventive and therapeutic strategies will need to address the specific mechanisms that explain this association in different groups of subjects.

Key Words: respiratory syncytial virus • asthma • lung function • infant • lower respiratory illness

Viral infections are the most consistent factor associated with the expression of asthma, regardless of its phenotypic characteristics, of the age of the patient, and of the phase of the natural history during which they occur. Evidence of viral infection is present in almost all cases of acute airway obstruction occurring during the first years of life, at a time when it is still not possible to determine if the affected child will go on to develop asthma or will only have transient episodes of wheezing. Nevertheless, the preschool is the period of life with the highest incidence of asthma (that is, the rate at which new cases of asthma develop) (1), and therefore one in which the role of viral infection in asthma pathogenesis may be of the greatest importance. Viruses or their products are also detected in the majority of older children and adults during asthma exacerbations (2), suggesting that either viruses themselves or the immune response associated with the viral infection may play an important role in acute asthma flare-ups.

In spite of this clear, strong temporal association, the role of viral infections in the pathogenesis of asthma is not well understood. Three main hypothetical scenarios have been proposed. A first possibility, especially applicable to the pediatric age, is that viral infections may either alter the development of immune responses or interfere with the normal pattern of lung growth and/or regulation of airway tone. In this scenario, viruses would be causal agents in the inception of asthma; the obvious corollary of this hypothetical scenario being that control of the relevant viral infections (by decreasing exposure or by the availability of active or passive immunization) should decrease the incidence of asthma. A second scenario is that viruses are merely triggers of airway obstruction in subjects who have either a pre-existing alteration in airway function or structure or a susceptibility to develop immune responses that predispose to airway obstruction. In this second scenario, control of viral infection could decrease morbidity associated with asthma-like symptoms, but would not decrease the incidence of the disease.

The purpose of this review is to propose a third hypothetical framework, which could explain the apparently contradictory information available both from human studies and experimental models. In this view, the nature of the response to the different viruses associated with asthma will depend on the genetic background of the individual, on concomitant environmental exposures, and on the timing of the infectious episode, in relation to the degree of maturation of both the immune system and the airways. Therefore, there is no single pattern of responses and of potential long-term sequealae associated with the development of asthma-related viral infections.

In the next paragraphs the evidence that supports this paradigm will be reviewed. Special emphasis will be placed on the first years of life, because this age period offers the best available data to assess the potential role of viral infections in the inception asthma.


    ASSOCIATION BETWEEN VIRAL INFECTIONS IN EARLY LIFE AND SUBSEQUENT ASTHMA
 TOP
 ABSTRACT
 ASSOCIATION BETWEEN VIRAL...
 HETEROGENEITY OF DETERMINANTS OF...
 CONCLUSIONS
 REFERENCES
 
Both longitudinal and retrospective studies have clearly established that children who develop bronchiolitis or who wheeze during what appear to be viral infections in the first 2 to 3 years of life are at increased risk of continued wheezing later in life (3, 4). Although this association seems clearly established, it is less clear if infections due to certain viruses are more likely to result in continued wheezing. The most widely studied virus is the respiratory syncytial virus (RSV), which is the most common cause of episodes of acute airway obstruction in infants and young children (5). In many studies, RSV was consistently found to be associated with subsequent wheezing (3, 4), and this strong association suggested that there were factors related to the specific immune responses to RSV that explained this connection between early lower respiratory illnesses (LRIs) and subsequent wheezing. In fact, data from our own studies initially suggested that children who had acute LRIs due to parainfluenza virus or in whom no virus was isolated also were at increased risk of subsequent wheezing, but given the lower incidence of LRIs due to these viruses, the association did not reach consistent statistical significance (3) and the temporal patterns observed were not as clear as those for RSV (see below). Recent observations suggest that metapneumoviruses (6) may also cause up to 12% of all cases of LRI in infants (7), but the association between LRI due to metapneumoviruses and subsequent asthma has not been explored. In addition, Copenhaver and coworkers (8) recently reported that, among infants with a strong family history of asthma and/or allergies, rhinovirus (RV) infection is a frequent cause of LRI during the first year of life. Interestingly, Korppi and colleagues (9) recently reported on factors associated with the etiology of viral LRI with wheezing in children admitted at or before the age of 2 years. When they compared 26 children who had RV-LRI with 24 who had RSV-LRI, they found that the former were significantly older (median, 13 vs. 5 months) and more likely to have eosinophilia and atopic dermatitis than children with RSV-LRI. When they assessed these children during the early school years, these same authors found that RV-LRI were significantly more likely to be associated with the development of asthma-like symptoms at that age than LRI due to other etiologies (10). The authors concluded that, for RV-LRIs, but not for RSV-LRIs, the connection with subsequent asthma could be explained by an increased susceptibility to RV-LRIs among children with an atopic background, in whom the first episode of RV-related wheezing could be the first manifestation of atopic asthma. Taken together, these findings suggest that the connection between viral LRI in early life and subsequent wheezing is not limited to LRI caused by RSV, and that the host's characteristics may determine if the child will continue wheezing after an LRI due to the different viruses that can cause these illnesses in early life.

This conclusion is compatible with the results of the Tucson Children's Respiratory Study (3). In this prospective study, unselected children were enrolled at birth and followed up to adolescence and beyond. Most LRIs were ascertained by a physician during the first 3 years of life, and virologic studies were performed for each LRI. Given the state of diagnostic tools at the time the LRIs were studied (between 1980 and 1987), RV was not included among the viruses targeted for detection. RSV was found to be the most frequent virus isolated during LRI, especially in the first year of life, and children with RSV-LRI were found to be at significantly increased risk of subsequent wheezing during the school years, a risk that significantly decreased with age after age 6. The connection between RSV-LRI and subsequent asthma was independent of, and was not mediated by, atopy: children with RSV-LRI were not more likely to become skin test positive to local aeroallergens during the school years when compared with those who did not have LRIs. Interestingly, LRIs associated with wheezing occurring during the second and third year of life were much more likely to be associated with subsequent atopic asthma (11), and these "late" LRIs were less likely to be due to RSV and more likely to be associated with negative cultures than those occurring during the first year of life. The patterns emerging from the Finnish study and from the Tucson study are thus similar: first year of life wheezing LRIs are most often associated with RSV infection, whereas those occurring during the second and third year of life are increasingly less likely to be due to RSV, and more likely to be associated with RV infection or with negative cultures. LRIs occurring during the second and third year of life are more strongly associated with subsequent atopic asthma than those occurring in the first year of life, although RSV-LRI are associated with increased risk of subsequent wheezing, albeit not apparently related to atopy.

The results of the Finnish (9) and Tucson studies, however, diverge in certain aspects from those of a report by Sigurs and coworkers in Sweden (4, 12, 13). Sigurs and colleagues recruited children who were hospitalized for RSV-LRI as infants and followed them and a group of control subjects up to the age of 13 years. They reported that at ages 3.5, 7, and 13 years, children who had RSV-LRIs were significantly more likely to have reports of wheezing and a diagnosis of asthma than control children, but were also significantly more likely to be sensitized to local aeroallergens. The authors proposed the hypothesis that an increased risk of subsequent development of atopy could explain at least in part the association between RSV-LRI and subsequent asthma. This hypothesis is not compatible with the data from the Tucson study and the Finnish study (9), which suggested that the connection between RSV and subsequent wheezing was not mediated by an increased likelihood of developing atopic asthma. Interestingly, Juntti and coworkers (14) reported results from a study similar in design to that of Sigurs and colleagues, that is, a comparison of subsequent atopic status and prevalence of asthma in children hospitalized as infants with a confirmed history of RSV-LRI and control subjects. The authors also found an increased risk of subsequent asthma associated with RSV LRI, but reported that children who had RSV-LRI were less likely than control children to be atopic during the school years.


    HETEROGENEITY OF DETERMINANTS OF LRI IN INFANCY
 TOP
 ABSTRACT
 ASSOCIATION BETWEEN VIRAL...
 HETEROGENEITY OF DETERMINANTS OF...
 CONCLUSIONS
 REFERENCES
 
How can these discrepancies be explained? One possibility has to do with the choice of controls when the design is a case-control study. One of the most difficult tasks in epidemiology is to identify the properly matched controls for the cases recruited for these types of studies. It is unlikely, however, that discrepancies between well designed studies such as those cited may be only attributable to technical issues. More likely, researchers in these different studies may (unknowingly) have selected as cases children in whom different pathogenetic factors were predominantly implicated in the causation pathway associated with the development of airway obstruction during acute viral infection. What would explain the discrepancies is thus that the population of children who develop clinically significant airway obstruction during early viral infection is highly heterogeneous.

What follows is a description of four areas of research that have provided evidence for different mechanisms of acute LRI and for the potential association between early LRI and subsequent asthma. The objective is, more than to provide an exhaustive account of all the factors implicated in these processes, to illustrate the complexity of the processes involved. It is clear that, in each individual subject, overlap may occur between these different mechanisms, and that the interaction between them will determine probabilistically the degree of severity and the overall prognosis in each case.

Congenital Alterations of Airway Function/Size
There is now well established evidence that indices of airway size obtained from either partial maximal flow–volume curves or other techniques used to assess lung function in noncooperating infants are inversely associated with the risk of having wheezing LRI during the first years of life. The observation that infants with preexisting diminished maximal flows/higher airway resistance are more likely to present with airway obstruction during viral infections has been replicated in five separate studies (1519). These observations are thus compatible with the hypothesis that diminished airway size is a risk factor for the development of wheezing illnesses during viral infections in early life. Moreover, it is also well established that the increased risk of wheezing that has been consistently reported for children whose mothers smoked during pregnancy may be mediated, to a significant extent, through the diminished maximal flows that are characteristically observed in children exposed to tobacco smoke products in utero (20). Given that airway resistance is a function of the fourth power of the radius of the bronchi, it has been proposed that the mechanism involved in this case is one of markedly increased functional obstruction in children with congenitally narrower airways (21). Moreover, because maximal flows increase with age relative to lung size (21), one would expect that this mechanism could mainly be active in the first years of life. Indeed, data from the Tucson Children's Respiratory Study (22) and from a similar longitudinal study in Perth, Australia (23) suggest that diminished airway function at birth is mainly associated with transient early wheezing, that is, with the development of one or more episodes of airway obstruction during the first three years of life, without further continuation of such episodes beyond that age. Interestingly, this is also the most frequently observed pattern of association between maternal smoking during pregnancy and childhood wheezing (24), suggesting once again that alterations in airway size due to both genetic or environmental factors may mediate this association.

The strong association between premorbid diminished airway function and transient earlier wheezing does not exclude the possibility that the former may also contribute to the risk for severe wheezing beyond the first 3 years of life. In fact, although relative to those in their peers, maximal expiratory flows improve during the preschool years in transient early wheezers (25), maximal flows are still significantly lower up to the age of 16 years in these children when compared to those of children who did not wheeze during viral infections in the first 3 years of life (unpublished observations). It is thus not surprising that, studying the children enrolled in the Perth study quoted earlier, Turner and coworkers observed that levels of lung function measured shortly after birth were significantly diminished in children who had reports of wheeze both at ages 6 and 11 years (26). Nevertheless, it is likely that congenitally diminished levels of lung function may not by themselves be sufficient to increase the risk for wheezing during the school years.

Congenital Alterations in the Regulation of Airway Tone
In some longitudinal studies, researchers were able to assess responses to either methacholine (27) or histamine (28) shortly after birth and before any LRI. These techniques are unfortunately cumbersome, and their continued use has also encountered significant resistance from ethics committees during the last 10 years. As a consequence, the data available are much scantier and less conclusive than that for earlier postnatal airway function tests without provocation, as described in the previous point. Nevertheless, some issues appear to be well established. Bronchial responses to histamine or methacholine are not associated with the level of baseline lung function in infants (29), and therefore, these two measurements assess potentially different aspects of airway physiology. Clarke and colleagues reported a significant association between bronchial hyperresponsiveness (BHR) to histamine and the subsequent risk of wheezing, presumably in relation to viral infections (30). The effects were stronger in girls than in boys. Among children enrolled in the same study from Perth quoted earlier, a group of slightly less than 100 were tested for BHR using histamine both shortly after birth and at the age of 6 years (29). The authors reported that early postnatal BHR to histamine was unrelated to BHR measured in these same children at age 6. However, early postnatal BHR was associated with wheezing at age 6 and with the level of lung function measured at that same age. Moreover, BHR measured at age 6 contributed to the risk of wheezing at that age independently of early postnatal BHR. BHR was not assessed in the early postnatal period in the Tucson Children's Respiratory Study, but BHR to cold dry air was measured at age 6 and BHR to methacholine and responses to albuterol were separately measured at age 11 (3, 31). Much like in the Perth study, BHR at age 6 was associated with wheezing at that age but was unrelated with a history of LRI in early life. However, although both responses to albuterol and methacholine were associated with current wheezing at age 11, only the former was associated with a history of RSV-LRI in the first 3 years of life.

The interpretation of this complex set of data is not straightforward. Most likely, both bronchial provocation tests performed shortly after birth and responses to albuterol measured during the school years detect intrinsic characteristics of the airways that are unrelated to airway inflammation. This is supported by the reported association of both these measures with two known polymorphisms in the coding region of the ß2-adrenergic receptor gene (32, 33) and by the lack of association of either of these measures with markers of atopy such as skin test reactivity. Therefore, it is possible that a congenital (or "intrinsic") component of the regulation of airway tone may predispose children to wheezing during viral infection in early life and to continue wheezing during the school years, thus explaining the connection between these two phenomena, independent of atopy. As describe earlier, however, the strength of this association decreases with age between 6 and 13 years (3), and the factors that determine this decreasing trend have not been elucidated. Interestingly, data from a longitudinal study in Dunedin, New Zealand, suggest that BHR to methacholine tends decreases between ages 9 and 15 years, but that this trend is only observed among nonatopic children, whereas the level of BHR tends to persist among atopic children (34). Therefore, a potential explanation for the diminishing trends for the association between RSV-LRI and subsequent wheezing could be the decreasing "intrinsic" BHR occurring during the school years.

Altered Immune Responses to Viral Infection
Several lines of research suggest that infants may be more prone to develop lower airway involvement during viral infection because they have immature immune responses. For example, infants produce low levels of protective antibodies against RSV (35), and cytokine responses of both the T helper-1 (Th1) and Th2 types to nonspecific stimuli are weaker in infants than in adults, with deficits in the former being much more prominent than those in Th2-like cytokines (36, 37). Moreover, epidemiologic data suggest that interferon-{gamma} (IFN-{gamma}) responses by peripheral blood mononuclear cells measured during the first months of life strongly predict the subsequent development of wheezing illnesses, presumably due to viruses, during the first year of life (38). A study of children hospitalized with severe RSV seemed to indirectly support this finding: children requiring mechanical ventilation had significantly lower IFN-{gamma} levels in nasopharyngeal secretions than those not requiring ventilatory support (39). However, one recent study found that levels of IFN-{gamma} were elevated in nasal secretions of infants with RSV infection, and that they correlated positively with the likelihood of wheezing during the infection (40). IFN-{gamma} was also found to be correlated with leukotriene levels in nasal secretions, and the latter has been found to be correlated with severity of acute bronchiolitis (41). These contradictory findings are surprising and difficult to explain. It is possible, however, that these studies may have targeted different groups of children, in whom different mechanisms are predominantly at work. For example, low baseline IFN-{gamma} production may be a risk factor for subsequent wheezing in infants in whom the mechanism of disease is related to increased susceptibility to viral infection due to a delayed development of IFN-{gamma} responses. Interestingly, infants with delayed IFN-{gamma} responses are also more likely to become sensitized to aeroallergens later in life (42). Therefore, delayed IFN-{gamma} responses could explain the link observed in certain studies between RSV illness in early life and subsequent allergic sensitization, particularly if more children belonging to this at risk category were enrolled in those studies (5). On the other hand, high producers IFN-{gamma} could be a different susceptibility group, in whom the pathogenesis of the acute RSV illness could be due to excessive IFN-{gamma} responses, which cause an immune-mediated disease mechanism. Paradoxically, these children should be expected to be less atopic later in life, a finding that is compatible with the report by Juntti and coworkers (14) cited earlier. In studies from random samples of the population in which both these types of subjects are enrolled (3), the expected result would be no association between RSV illness and atopic sensitization. Unfortunately, no studies are available in which IFN-{gamma} responses were measured before and during RSV illness in the same children, and therefore, the confirmation of the existence of these two different, IFN-{gamma}–related mechanisms for RSV illness remains speculative. However, studies in which an attempt was made to identify children who would or would not go on to have persistent wheeze and/or atopy after an acute LRI in early life support the hypothesis that the latter is not a homogenous group. Martinez and colleagues showed children with wheezing LRI who subsequently developed asthma had significantly higher total serum IgE and eosinophil levels during the acute phase than during the convalescent phase of the LRI, whereas those who did not go on to develop asthma showed no such acute responses (43). Moreover, children who had nonwheezing LRI were less likely to have high serum IgE levels later in life than those who did not have LRI (44). The data thus suggests that outcome of early life LRI may vary according to the nature of the immune response to the virus and that, depending on which group of subjects predominates in each study, early LRI may be found to be associated with increased or decreased likelihood of subsequent atopy.

Immune mechanisms other than those associated with IFN-{gamma} responses have also been implicated in the association between RSV illness and subsequent wheezing. Bont and colleagues (45) reported that increased monocyte interleukin-10 responses during acute RSV illness were directly associated with the likelihood of subsequent persistent wheezing, and this effect was independent of IFN-{gamma} responses. It is this likely that a number of different immune mechanisms may be involved in the connection between RSV illness in early life and subsequent persistent wheezing and asthma.

Genetic Determinants of RSV Illness
In spite of the extraordinary advances in the development of new technologies to study the genetics of complex disease, there have been surprisingly few studies of the genetics of early life LRI and its potential association with the subsequent development of asthma. This paucity may be in part due to the intrinsic difficulty to demonstrate that familial aggregation of LRI is attributable to common genetic background and not to common environment. For example, if young siblings were found to be more susceptible to RSV illness if their living siblings also had RSV, the most reasonable explanation would be a common (or mutual) infectious source. Moreover, if early life LRI is a highly heterogeneous condition and, as suggested earlier, both low and high responses of the same cytokine (e.g., IFN-{gamma}) are associated with increased risk of acute illness, studies that included all affected children as probands could not be very successful.

Hull and coworkers first reported that the A allele of a single nucleotide polymorphism (SNP) at position –251 from the transcription start site in the promoter region of IL-8 was associated with severe RSV illness requiring hospitalization (46). This group of researchers also reported that the same allele (and other polymorphisms linked with it in the same haplotype) was associated with the likelihood of continued wheezing 5 to 6 years after an episode of RSV requiring hospitalization (47). Functional studies indicated that the haplotype linked with the A allele was associated with increased transcription rates for interleukin-8 (48), suggesting that increased interleukin-8 responses could be risk factors for persistent wheezing after RSV. However, Heinzmann and colleagues (49) studied the same SNP in older children, and found that susceptibility to asthma was associated with the T allele, exactly the opposite effect to that reported by Hull and coworkers. If these apparently contradictory findings are replicated in other populations, they would confirm that the mechanisms that determine the association between early life events and subsequent asthma are highly heterogeneous. It is possible that, much like seems to be the case for IFN-{gamma}, inflammatory mediators such as interleukin-8 may have opposite effects on disease susceptibility, depending on the context in which they are expressed.


    CONCLUSIONS
 TOP
 ABSTRACT
 ASSOCIATION BETWEEN VIRAL...
 HETEROGENEITY OF DETERMINANTS OF...
 CONCLUSIONS
 REFERENCES
 
Small airway size, congenital and acquired dysregulation of airway tone, and altered immune responses to viral infection seem to be implicated in the association between LRI in early life and the subsequent development of persistent wheezing and asthma. Often, and especially in the case of immune mechanisms, current evidence suggests nonlinear associations, with responses at both the high and low end of the spectrum being associated with increased risk. This complex state of affairs may explain the apparently contradictory findings of recently published reports: children in whom different disease mechanisms are involved could have been preferentially included in these different studies. Prevention and treatment of early LRI and subsequent asthma may require the development of treatments that specifically target these different mechanisms.


    FOOTNOTES
 
Conflict of Interest Statement: F.D.M. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. He received $13,100 in 2002, $3,000 in 2003, and $6,500 in 2004 from Merck for a presentation and Merck Scientific Advisory Board fees; he also received monies from GlaxoSmithKline (GSK) for presenting at a sponsored event in 2003 ($1,500); as a member of the AstraZeneca Speaker's Bureau, he received $10,000 in 2002 and $2,500 in 2003 for lectures.

(Received in original form April 22, 2005; accepted in final form June 21, 2005)


    REFERENCES
 TOP
 ABSTRACT
 ASSOCIATION BETWEEN VIRAL...
 HETEROGENEITY OF DETERMINANTS OF...
 CONCLUSIONS
 REFERENCES
 

  1. King ME, Mannino DM, Holguin F. Risk factors for asthma incidence: a review of recent prospective evidence. Panminerva Med 2004;46:97–110.[Medline]
  2. Message SD, Johnston SL. Viruses in asthma. Br Med Bull 2002;61:29–43.[Abstract/Free Full Text]
  3. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;353:541–545.[CrossRef][Medline]
  4. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, Kjellman B. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005;171:137–141.[Abstract/Free Full Text]
  5. Wright AL, Taussig LM, Ray CG, Harrison HR, Holberg CJ. The Tucson Children's Respiratory Study: II. Lower respiratory tract illness in the first year of life. Am J Epidemiol 1989;129:1232–1246.[Abstract/Free Full Text]
  6. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, Osterhaus AD. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001;7:719–724.[CrossRef][Medline]
  7. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, Wright PF, Crowe JE Jr. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004;350:443–450.[Abstract/Free Full Text]
  8. Copenhaver CC, Gern JE, Li Z, Shult PA, Rosenthal LA, Mikus LD, Kirk CJ, Roberg KA, Anderson EL, Tisler CJ, et al. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med 2004;170:175–180.[Abstract/Free Full Text]
  9. Korppi M, Kotaniemi-Syrjanen A, Waris M, Vainionpaa R, Reijonen TM. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J 2004;23:995–999.[Medline]
  10. Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, Waris M, Korhonen K, Korppi M. Rhinovirus-induced wheezing in infancy–the first sign of childhood asthma? J Allergy Clin Immunol 2003;111:66–71.[CrossRef][Medline]
  11. Halonen M, Stern DA, Lohman IC, Wright AL, Brown MA, Martinez FD. Two subphenotypes of childhood asthma that differ in maternal and paternal influences on asthma risk. Am J Respir Crit Care Med 1999;160:564–570.[Abstract/Free Full Text]
  12. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000;161:1501–1507.[Abstract/Free Full Text]
  13. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995;95:500–505.[Abstract/Free Full Text]
  14. Juntti H, Kokkonen J, Dunder T, Renko M, Niinimaki A, Uhari M. Association of an early respiratory syncytial virus infection and atopic allergy. Allergy 2003;58:878–884.[CrossRef][Medline]
  15. Martinez FD, Morgan WJ, Wright AL, Holberg C, Taussig LM. Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life. Am Rev Respir Dis 1991;143:312–316.[Medline]
  16. Tager IB, Hanrahan JP, Tosteson TD, Castile RG, Brown RW, Weiss ST, Speizer FE. Lung function, pre- and post-natal smoke exposure, and wheezing in the first year of life. Am Rev Respir Dis 1993;147:811–817.[Medline]
  17. Dezateux C, Stocks J, Dundas I, Fletcher ME. Impaired airway function and wheezing in infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J Respir Crit Care Med 1999;159:403–410.[Abstract/Free Full Text]
  18. Young S, Arnott J, O'Keeffe PT, Le Souef PN, Landau LI. The association between early life lung function and wheezing during the first 2 yrs of life. Eur Respir J 2000;15:151–157.[Abstract]
  19. Murray CS, Pipis SD, McArdle EC, Lowe LA, Custovic A, Woodcock A. Lung function at one month of age as a risk factor for infant respiratory symptoms in a high risk population. Thorax 2002;57:388–392.[Abstract/Free Full Text]
  20. Stocks J, Dezateux C. The effect of parental smoking on lung function and development during infancy. Respirology 2003;8:266–285.[CrossRef][Medline]
  21. Martinez FD. Sudden infant death syndrome and small airway occlusion: facts and a hypothesis. Pediatrics 1991;87:190–198.[Abstract/Free Full Text]
  22. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ, and The Group Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133–138.[Abstract/Free Full Text]
  23. Turner SW, Palmer LJ, Rye PJ, Gibson NA, Judge PK, Young S, Landau LI, Le Souef PN. Infants with flow limitation at 4 weeks: outcome at 6 and 11 years. Am J Respir Crit Care Med 2002;165:1294–1298.[Abstract/Free Full Text]
  24. Stein RT, Holberg CJ, Sherrill DL, Wright AL, Morgan WJ, Taussig LM, Martinez FD. The influence of parental smoking on respiratory symptoms in the first decade of life: The Tucson Children's Respiratory Study. Am J Epidemiol 1999;149:1030–1037.[Abstract/Free Full Text]
  25. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133–138.[Abstract/Free Full Text]
  26. Turner SW, Palmer LJ, Rye PJ, Gibson NA, Judge PK, Cox M, Young S, Goldblatt J, Landau LI, Le Souef PN. The relationship between infant airway function, childhood airway responsiveness, and asthma. Am J Respir Crit Care Med 2004;169:921–927.[Abstract/Free Full Text]
  27. Chan KN, Silverman M. Increased airway responsiveness in children of low birth weight at school age: effect of topical corticosteroids. Arch Dis Child 1993;69:120–124.[Abstract]
  28. Stick SM, Turnbull S, Chua HL, Landau LI, Lesouef PN. Bronchial responsiveness to histamine in infants and older children. Am Rev Respir Dis 1990;142:1143–1146.[Medline]
  29. Palmer LJ, Rye PJ, Gibson NA, Burton PR, Landau LI, Lesouef PN. Airway responsiveness in early infancy predicts asthma, lung function, and respiratory symptoms by school age. Am J Respir Crit Care Med 2001;163:37–42.[Abstract/Free Full Text]
  30. Clarke JR, Salmon B, Silverman M. Bronchial responsiveness in the neonatal period as a risk factor for wheezing in infancy. Am J Respir Crit Care Med 1995;151:1434–1440.[Abstract]
  31. Lombardi E, Morgan WJ, Wright AL, Stein RT, Holberg CJ, Martinez FD. Cold air challenge at age 6 and subsequent incidence of asthma: a longitudinal study. Am J Respir Crit Care Med 1997;156:1863–1869.[Abstract/Free Full Text]
  32. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997;100:3184–3188.[Medline]
  33. Turner SW, Khoo SK, Laing IA, Palmer LJ, Gibson NA, Rye P, Landau LI, Goldblatt J, Le Souef PN. beta2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and asthma in infants and children. Clin Exp Allergy 2004;34:1043–1048.[CrossRef][Medline]
  34. Burrows B, Sears MR, Flannery EM, Herbison GP, Holdaway MD, Silva PA. Relation of the course of bronchial responsiveness from age 9 to age 15 to allergy. Am J Respir Crit Care Med 1995;152:1302–1308.[Abstract]
  35. Brandenburg AH, Groen J, van Steensel-Moll HA, Claas EC, Rothbarth PH, Neijens HJ, Osterhaus AD. Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection. J Med Virol 1997;52:97–104.[CrossRef][Medline]
  36. Chalmers IM, Janossy G, Contreras M, Navarrete C. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 1998;92:11–18.[Abstract/Free Full Text]
  37. Prescott SL, Macaubas C, Holt BJ, Smallacombe TB, Loh R, Sly PD, Holt PG. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998;160:4730–4737.[Abstract/Free Full Text]
  38. Guerra S, Lohman IC, Halonen M, Martinez FD, Wright AL. Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age. Am J Respir Crit Care Med 2004;169:70–76.[Abstract/Free Full Text]
  39. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JM, Pekelharing-Berghuis M, van Diemen-Steenvoorde RA, Kimpen JL. Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis 2001;184:355–358.[CrossRef][Medline]
  40. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC II, Welliver RC. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 1999;103:630–636.[CrossRef][Medline]
  41. Volovitz B, Welliver RC, De Castro G, Krystofik DA, Ogra PL. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res 1988;24:504–507.[Medline]
  42. Martinez FD, Stern DA, Wright AL, Holberg CJ, Taussig LM, Halonen M. Association of interleukin-2 and interferon-gamma production by blood mononuclear cells in infancy with parental allergy skin tests and with subsequent development of atopy. J Allergy Clin Immunol 1995;96:652–660.[CrossRef][Medline]
  43. Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M. Differential immune responses to acute lower respiratory illness in early life by subsequent development of persistent wheezing and asthma. J Allergy Clin Immunol 1998;102:915–920.[CrossRef][Medline]
  44. Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M, Associates GHM. Association of non-wheezing lower respiratory tract illnesses in early life with persistently diminished serum IgE levels. Thorax 1995;50:1067–1072.[Abstract]
  45. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JT, Geelen SM, Kimpen J. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. Am J Respir Crit Care Med 2000;161:1518–1523.[Abstract/Free Full Text]
  46. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000;55:1023–1027.[Abstract/Free Full Text]
  47. Goetghebuer T, Isles K, Moore C, Thomson A, Kwiatkowski D, Hull J. Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis. Clin Exp Allergy 2004;34:801–803.[CrossRef][Medline]
  48. Hacking D, Knight JC, Rockett K, Brown H, Frampton J, Kwiatkowski DP, Hull J, Udalova IA. Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun 2004;5:274–282.[CrossRef][Medline]
  49. Heinzmann A, Ahlert I, Kurz T, Berner R, Deichmann KA. Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 2004;114:671–676.[CrossRef][Medline]



This article has been cited by other articles:


Home page
J. Virol.Home page
P. L. Collins and B. S. Graham
Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis
J. Virol., March 1, 2008; 82(5): 2040 - 2055.
[Full Text] [PDF]


Home page
J Trop PediatrHome page
M. U. Ferreira, G. Rubinsky-Elefant, T. G. de Castro, E. H. E. Hoffmann, M. da Silva-Nunes, M. A. Cardoso, and P. T. Muniz
Bottle Feeding and Exposure to Toxocara as Risk Factors for Wheezing Illness among Under-five Amazonian Children: A Population-based Cross-sectional Study
J Trop Pediatr, April 1, 2007; 53(2): 119 - 124.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martinez, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martinez, F. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS